WebMD the Magazine is now part of the iPad app world. WebMD said Wednesday that the no-cost app and magazine subscription will be available through Apple's Newsstand, and includes videos, slideshows and blogs that open inside the app (inaugural cover above). WebMD said in a statement that each print issue reaches 10 million readers.
Journal EMBO Molecular Medicine
is converting to an open-access model and will be part of publisher Wiley-Blackwell's Wiley Open Access publishing program, Wiley and EBMO said. This is the second of EMBO's four journals to convert from a subscription-based model to open-access; Molecular Systems Biology
made the switch in 2005. Future articles will be published under the Creative Commons Attribution Non-Commercial License.
Eli Lilly and Boehringer Ingelheim
's diabetes 2 drug Jentadueto has hit pharmacy shelves just a little more than a month after receiving FDA approval. The twice-daily tablet combines the DPP-4 inhibitor Tradjenta (linagliptin) and metformin in one table, and comes in three strengths. The two companies initially teamed up to promote Tradjenta
, an alliance which ultimately led Lilly and Amylin to dissolve
their preexisting partnership to market diabetes med Byetta and Bydureon, the weekly version of Byetta which the FDA approved January 30.